ArticleNeurophotonics2026
Cellular multipoint adaptive technology for two-photon mesoscope.
Article in Neurophotonics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: In mesoscopic imaging research in neuroscience, achieving high spatial resolution optical imaging across the entire field of view (FOV) remains critical. This directly determines whether researchers can precisely analyze the large-scale dynamic activities of neural circuits at the single-cell or even subcellular level. Consistent optical quality throughout the entire imaging FOV is essential to accurately capture the spatiotemporal patterns of neural activity across brain regions, thereby providing a powerful tool for understanding the circuit mechanisms underlying cognition, behavior, and disease at cellular and subcellular resolution Aim: This study aims to develop a technology that extends the imaging FOV in a two-photon mesoscope while enhancing the optical quality across the entire FOV Approach: This study introduces an innovative approach that combines block scanning with adaptive optical (AO) correction through a bioinspired honeycomb-based cellular multipoint adaptive technology (CMAT) to achieve mesoscopic two-photon imaging. This system enables unprecedented large-FOV, high-resolution imaging by dividing an Results: Comprehensive evaluation using standard samples and transgenic mouse models demonstrated that the CMAT significantly enhances the imaging performance of the two-photon mesoscope. This technique extends the effective two-photon imaging FOV from Conclusion: CMAT significantly extends the effective FOV and enhances the optical quality of the two-photon mesoscope system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.